Canadian Supreme Court upholds, but limits, AZT patent.
On 5 December 2002, the Supreme Court of Canada ended a long-running dispute when it unanimously upheld the validity of the Canadian patent on the antiretroviral drug zidovudine (AZT) held by Glaxo Wellcome (now GlaxoSmithKline).
Elliott
Richard
R
D002170:Canada; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine
D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine